Ceftizoxime FDA Link

A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.

Also Known As:

Cefizox; Ceftizoxime Sodium; Ceftizoxime Monosodium Salt; FK-749; FK749; FR-13749; SK&F 88373-2; SKF-88373; FK 749; FR 13749; FR13749; Monosodium Salt, Ceftizoxime; SK&F 88373 2; SK&F 883732; SKF 88373; SKF88373; Salt, Ceftizoxime Monosodium; Sodium, Ceftizoxime; 5- Thia- 1- azabicyclo(4.2.0)oct- 2- ene- 2- carboxylic acid, 7- (((2- amino- 4- thiazolyl)(methoxyimino)acetyl)amino)- 8- oxo- , (6R-(6alpha,7beta(Z)))-

Pharmalogical Action Categories:

Anti-Bacterial Agents

Organic Chemicals: 133
- Amides: 2428
  - Lactams: 2198
    - beta-Lactams: 2386
      - Cephalosporins: 4007
        Cephacetrile: 28
        Cefotaxime: 1712
        Ceftizoxime: 235
- Sulfur Compounds: 278
  - Thiazines: 3
    - Cephalosporins: 4007
      - Cephacetrile: 28
        Cefotaxime: 1712
        Ceftizoxime: 235
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - beta-Lactams: 2386
      - Cephalosporins: 4007
        Cephacetrile: 28
        Cefotaxime: 1712
        Ceftizoxime: 235

ceftizoxime alapivoxil

Bio-Agent Context: Research Results